Great Debate: Chronic Rhinosinusitis Quandaries: Critical Questions and Debates on Utilization of Biologics

Sunday, September 29, 2024

11:00 AM – 12:00 PM EDT

Location: MBCC, Art Deco 228AB

CME/MOC Credit: 1

Disclosure(s):

Elina M. Toskala, MBA, PhD, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Stella E. Lee, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: In this debate, 4 -5 statements associated with the use of biologics in the management of chronic rhinosinusitis will be presented. The audience will initially provide whether they agree or disagree with the statement. Then, each speaker will argue either the pro or con of the statement. This will be followed by a repeat survey of the audience.

Learning Objectives:

Discuss the risks and benefits of biologics for CRS.
Examine the roles of functional endoscopic surgery and biologics in CRSwNP treatment algorithms.
Contrast the use of biologics and prednisone in the management of CRS with NP.

Moderator(s)

AL

Amber U. Luong, MD, PhD

Professor of Otolaryngology, Vice Chair of Academic Affairs
University of Texas Houston, McGovern Medical School
Houston, TX, United States

Disclosure information not submitted.

Debate Speaker(s)

Elina M. Toskala, MD, PhD, MBA

Professor, Vice Chair
Thomas Jefferson University - Department of Otolaryngology
Philadelphia, Pennsylvania, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Stella E. Lee, MD

Section Chief—Rhinology
Division of Otolaryngology—Head & Neck Surgery, Brigham and Women’s Hospital, Harvard Medical School
Weston, MA, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.